Eléments de l'association

	Philippe Damier	11
	Antiparkinson Agents (adverse effects)	43
	Philippe Damier *Sauf* Antiparkinson Agents (adverse effects)"	7
	Antiparkinson Agents (adverse effects) *Sauf* Philippe Damier"	39
	Philippe Damier Et Antiparkinson Agents (adverse effects)	4
	Philippe Damier Ou Antiparkinson Agents (adverse effects)	50
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000285	Christopher G. Goetz [États-Unis] ; Eugene Laska [États-Unis] ; Christine Hicking [Allemagne] ; Philippe Damier [France] ; Thomas Müller [Allemagne] ; John Nutt [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne]	Placebo influences on dyskinesia in Parkinson's disease
000317	Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne]	Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial
000447	Sylvie Raoul [France] ; Mirella Faighel [France] ; Isabelle Rivier [France] ; Marc Vérin [France] ; Youenn Lajat [France] ; Philippe Damier [France]	Staged lesions through implanted deep brain stimulating electrodes: A new surgical procedure for treating tremor or dyskinesias
000571	Bejjani [France] ; Philippe Damier [France] ; Isabelle Arnulf [France] ; Sawas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Yves Agid [France] ; Bernard Pidoux [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Claude Marsault [France]	Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024